PATENT CLAIM ANALYSIS

Application Number: 15761146
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "052000"]

Abstract:
Vitamin B12 for use in the treatment of a condition in a subject is administered sublingually. The vitamin B12 is dispersed in a hydrophobic continuous phase, such as oil or fat. The condition to be treated is vitamin B12 deficiency.

Claim (Index 9):
Vitamin B12 according to  claim 1 , wherein the condition is chosen from vitamin B12 deficiency, autism spectrum disorder, fatigue, memory deficiency, ALS, Alzheimer, deficiency caused by drug abuse, thinning of the stomach lining, vitamin B12 deficiency after surgery in which part of the stomach and/or small intestine is removed, Crohn's disease, celiac disease, Graves' disease, systemic lupus erythematosus and migraine.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.41935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14647914', '14226661', '11776329', '14227707', '11579527']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7638686871799596
- 35 USC 102 Novelty (BERT): 0.459548815563997
- Combined Prediction Score: 0.7334367000183634
- Mean Citation Score: 162.694774
- Max Citation Score: 172.43538
- Similarity Product: 147.8783778680491

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test